SGL Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SGL Investment Advisors's LLY Position: Q2 2026 in Review
SGL Investment Advisors increased its Eli Lilly (LLY) stake by 16% in Q2 2026, buying an estimated $128K and bringing the position to 923 shares worth $1.14M. The position accounts for 0.39% of the portfolio, ranked #55.
SGL Investment Advisors first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- SGL Investment Advisors held 923 shares of Eli Lilly worth $1.14M as of Q2 2026.
- SGL Investment Advisors bought 125 Eli Lilly shares in Q2 2026, an estimated $128K.
- Eli Lilly made up 0.39% of SGL Investment Advisors's portfolio in Q2 2026, its #55 holding.
- SGL Investment Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on SGL Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.